PL139646B1 - Process for preparing novel 5-/substituted phenyl/-hydantoins - Google Patents
Process for preparing novel 5-/substituted phenyl/-hydantoins Download PDFInfo
- Publication number
- PL139646B1 PL139646B1 PL1983244350A PL24435083A PL139646B1 PL 139646 B1 PL139646 B1 PL 139646B1 PL 1983244350 A PL1983244350 A PL 1983244350A PL 24435083 A PL24435083 A PL 24435083A PL 139646 B1 PL139646 B1 PL 139646B1
- Authority
- PL
- Poland
- Prior art keywords
- formula
- compounds
- sodium
- solution
- ether
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/438,199 US4452806A (en) | 1982-11-01 | 1982-11-01 | Treating diabetic complications with 5-(substituted phenyl)hydantoins |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL244350A1 PL244350A1 (en) | 1985-02-13 |
| PL139646B1 true PL139646B1 (en) | 1987-02-28 |
Family
ID=23739660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1983244350A PL139646B1 (en) | 1982-11-01 | 1983-10-28 | Process for preparing novel 5-/substituted phenyl/-hydantoins |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US4452806A (esLanguage) |
| JP (1) | JPS5998063A (esLanguage) |
| KR (1) | KR860001507B1 (esLanguage) |
| CA (1) | CA1203241A (esLanguage) |
| DK (1) | DK158724C (esLanguage) |
| ES (1) | ES526841A0 (esLanguage) |
| FI (1) | FI80265C (esLanguage) |
| GR (1) | GR79638B (esLanguage) |
| HU (1) | HU191887B (esLanguage) |
| PL (1) | PL139646B1 (esLanguage) |
| PT (1) | PT77578A (esLanguage) |
| YU (1) | YU43556B (esLanguage) |
| ZA (1) | ZA838092B (esLanguage) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20030060898A (ko) | 2000-09-25 | 2003-07-16 | 이비덴 가부시키가이샤 | 반도체소자,반도체소자의 제조방법,다층프린트배선판 및다층프린트배선판의 제조방법 |
| IT1319201B1 (it) * | 2000-10-12 | 2003-09-26 | Nicox Sa | Farmaci per il diabete. |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4189587A (en) * | 1977-04-05 | 1980-02-19 | Ciba-Geigy Corporation | 1,3-Diaminomethyl-hydantoin additives for lubricating oils |
| FR2458546A1 (fr) * | 1979-06-07 | 1981-01-02 | Hoechst France | Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant |
-
1982
- 1982-11-01 US US06/438,199 patent/US4452806A/en not_active Expired - Fee Related
-
1983
- 1983-10-26 GR GR72794A patent/GR79638B/el unknown
- 1983-10-28 PT PT77578A patent/PT77578A/pt not_active IP Right Cessation
- 1983-10-28 PL PL1983244350A patent/PL139646B1/pl unknown
- 1983-10-28 ES ES526841A patent/ES526841A0/es active Granted
- 1983-10-31 YU YU2167/83A patent/YU43556B/xx unknown
- 1983-10-31 FI FI833993A patent/FI80265C/fi not_active IP Right Cessation
- 1983-10-31 KR KR1019830005157A patent/KR860001507B1/ko not_active Expired
- 1983-10-31 ZA ZA838092A patent/ZA838092B/xx unknown
- 1983-10-31 CA CA000440069A patent/CA1203241A/en not_active Expired
- 1983-10-31 HU HU833734A patent/HU191887B/hu not_active IP Right Cessation
- 1983-11-01 DK DK499983A patent/DK158724C/da not_active IP Right Cessation
- 1983-11-01 JP JP58205707A patent/JPS5998063A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DK499983A (da) | 1984-05-02 |
| ZA838092B (en) | 1985-06-26 |
| YU216783A (en) | 1986-02-28 |
| HU191887B (en) | 1987-04-28 |
| CA1203241A (en) | 1986-04-15 |
| US4452806A (en) | 1984-06-05 |
| YU43556B (en) | 1989-08-31 |
| DK499983D0 (da) | 1983-11-01 |
| PT77578A (en) | 1983-11-01 |
| FI80265C (fi) | 1990-05-10 |
| PL244350A1 (en) | 1985-02-13 |
| KR860001507B1 (ko) | 1986-09-30 |
| FI833993A0 (fi) | 1983-10-31 |
| JPH0465832B2 (esLanguage) | 1992-10-21 |
| KR840006630A (ko) | 1984-12-01 |
| DK158724B (da) | 1990-07-09 |
| ES8507119A1 (es) | 1985-05-01 |
| DK158724C (da) | 1990-11-19 |
| FI833993A7 (fi) | 1984-05-02 |
| FI80265B (fi) | 1990-01-31 |
| ES526841A0 (es) | 1985-05-01 |
| GR79638B (esLanguage) | 1984-10-31 |
| JPS5998063A (ja) | 1984-06-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI62838B (fi) | Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening | |
| US4198421A (en) | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles | |
| GB2140412A (en) | Thiazolidine derivatives, process for the preparation and pharmaceutical compositions thereof | |
| CN112430221B (zh) | 用于预防、治疗或减轻高尿酸血症或痛风的化合物及其应用 | |
| JPS6052157B2 (ja) | スピロ−多環式イミダゾリジンジオン誘導体 | |
| PT92180B (pt) | Processo para a preparacao de novas mevalonolactonas do tipo tienopiridina e de composicoes farmaceuticas que as contem | |
| US4259344A (en) | Sulfur-containing benzimidazole derivatives | |
| CA1269389A (en) | PROCESS FOR PREPARING .gamma.-BUTYROLACTONE DERIVATIVES, AND IMMUNOMODULATING COMPOSITIONS CONTAINING THE SAME AS ACTIVE INGREDIENTS | |
| PL139646B1 (en) | Process for preparing novel 5-/substituted phenyl/-hydantoins | |
| AU644454B2 (en) | Novel oxazole derivatives, a preparation method therefor and pharmaceutical compositions containing same | |
| FI87460C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 7-fenyl-, naftyl- och bensofuranylisotiazolo/4,5-d/-1,2,3-triazin-4(3h)-oner | |
| EP0335979A1 (en) | Thienopyrimidine derivatives | |
| PL147400B1 (en) | Method of obtaining novel derivatives of spiro imidazolidine | |
| US5326883A (en) | Oxime ether derivatives having lipoxygenase inhibitory activity | |
| US4176190A (en) | Diuretic and saliuretic sulphamoylbenzoic acids | |
| GB2192002A (en) | Glycine derivatives | |
| NZ198192A (en) | 1-substituted-1h-tetrazol-5-amines and pharmaceutical compositions | |
| US4882340A (en) | Benzofuran derivative and processes for preparing the same | |
| US6194585B1 (en) | Process for preparing 5-lipoxygenase inhibitors | |
| AU610629B2 (en) | Improvements in or relating to leukotriene antagonists | |
| EP0294994B1 (en) | 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides | |
| JPH08505877A (ja) | 抗増殖剤としての縮合複素環式グルタミン酸誘導体 | |
| EP0666253A1 (en) | N-t-BUTYLANILINE ANALOG AND LIPID LEVEL DEPRESSANT CONTAINING THE SAME | |
| CA1195689A (en) | Aldose reductase inhibiting 5-(2-alkoxy-3-substituted phenyl) hydantoins | |
| US20250129055A1 (en) | Glucoside derivative, and preparation method therefor and application thereof |